Morgan Sarah L, Naderi Pourya, Koler Katjuša, Pita-Juarez Yered, Prokopenko Dmitry, Vlachos Ioannis S, Tanzi Rudolph E, Bertram Lars, Hide Winston A
Harvard Medical School Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, United States.
Harvard Medical School, Boston, MA, United States.
Front Aging Neurosci. 2022 Jun 24;14:846902. doi: 10.3389/fnagi.2022.846902. eCollection 2022.
Alzheimer's disease (AD) is a complex neurodegenerative disorder. The relative contribution of the numerous underlying functional mechanisms is poorly understood. To comprehensively understand the context and distribution of pathways that contribute to AD, we performed text-mining to generate an exhaustive, systematic assessment of the breadth and diversity of biological pathways within a corpus of 206,324 dementia publication abstracts. A total of 91% (325/335) of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways have publications containing an association at least 5 studies, while 63% of pathway terms have at least 50 studies providing a clear association with AD. Despite major technological advances, the same set of top-ranked pathways have been consistently related to AD for 30 years, including , , , , , , , , and . AD pathways studied appear biased: animal model and human subject studies prioritize different AD pathways. Surprisingly, human genetic discoveries and drug targeting are not enriched in the most frequently studied pathways. Our findings suggest that not only is this disorder incredibly complex, but that its functional reach is also nearly global. As a consequence of our study, research results can now be assessed in the context of the wider AD literature, supporting the design of drug therapies that target a broader range of mechanisms. The results of this study can be explored at www.adpathways.org.
阿尔茨海默病(AD)是一种复杂的神经退行性疾病。众多潜在功能机制的相对贡献尚不清楚。为了全面了解导致AD的通路的背景和分布,我们进行了文本挖掘,以对206324篇痴呆症发表摘要语料库中的生物通路的广度和多样性进行详尽、系统的评估。共有91%(325/335)的京都基因与基因组百科全书(KEGG)通路有至少5项研究的出版物包含关联,而63%的通路术语有至少50项研究提供与AD的明确关联。尽管有重大技术进步,但30年来,同一组排名靠前的通路一直与AD相关,包括[此处原文缺失具体通路名称]。所研究的AD通路似乎存在偏差:动物模型和人体研究优先考虑不同的AD通路。令人惊讶的是,人类遗传学发现和药物靶向在最常研究的通路中并未富集。我们的研究结果表明,这种疾病不仅极其复杂,而且其功能影响范围几乎是全局性的。作为我们研究的结果,现在可以在更广泛的AD文献背景下评估研究结果,支持针对更广泛机制的药物治疗设计。本研究结果可在www.adpathways.org上进行探索。